Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia.
about
A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal CancerRanibizumab and aflibercept for the treatment of wet age-related macular degeneration.EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.Intravitreal administration of bevacizumab: pros and cons.
P2860
Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Bevacizumab for choroidal neov ...... ation and pathological myopia.
@en
type
label
Bevacizumab for choroidal neov ...... ation and pathological myopia.
@en
prefLabel
Bevacizumab for choroidal neov ...... ation and pathological myopia.
@en
P2860
P50
P921
P1476
Bevacizumab for choroidal neov ...... ation and pathological myopia.
@en
P2093
Saba Hashemi
P2860
P304
P356
10.1517/14712598.2014.967210
P407
P577
2014-10-04T00:00:00Z